Top Markets
#1 DogBull DogBull +104.58%
#2 Siacoin Siacoin +51.37%
#3 ADO Protocol ADO Protocol +46.38%
#4 MarsCoin MarsCoin +44.35%
#5 UnifAI Network UnifAI Network +42.92%
#6 Magma Finance Magma Finance +28.97%
#7 Useless Coin Useless Coin +26.04%
#8 Ontology Gas Ontology Gas +20.36%
#9 Cash Cat Cash Cat +17.48%
#10 Apertum Apertum +14.63%
Coin of the day
DogBull DogBull
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Cuorips Inc. Cuorips Inc.

Cuorips Inc.

4894
Kedudukan dalam Saham #16184
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived... Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Harga Saham
$37.25
Modal Pasaran
$307.63M
Perubahan (1 hari)
-1.55%
Perubahan (1 tahun)
-26.02%
Negara
JP
Perdagangan Cuorips Inc. (4894)

Kategori

Healthcare
Hasil untuk Cuorips Inc. (4894)
Hasil pada Sep 2026 TTM: 0
Menurut laporan kewangan terkini daripada Cuorips Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Cuorips Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH